Radiology, Vol 187, 701-706, Copyright © 1993 by Radiological Society of North America

ARTICLES

A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies

AA Bogdanov Jr, R Weissleder, HW Frank, AV Bogdanova, N Nossif, BK Schaffer, E Tsai, MI Papisov and TJ Brady
Department of Radiology, Massachusetts General Hospital, Charlestown 02129.

The authors developed and evaluated a polymer as a contrast agent for magnetic resonance (MR) angiography. The agent consists of a monomethoxy ether of poly(ethylene glycol) covalently attached to poly(L-lysine) (PL), with PL serving as the carrier of gadolinium diethylenetriaminepentaacetic acid (DTPA). Immunogenicity and toxicity studies were performed in mice, and biokinetic and metabolic studies were performed in rats. Dose response studies were performed with a three-dimensional time-of-flight sequence in eight rats. No permanent immune response was elicited against Gd-DTPA or the carrier molecule, and accumulation in organs of the reiculoendothelial system was minimal. The blood half-life of the agent was 14 hours. A dose of 20 mumol of gadolinium per kilogram of body weight was sufficient to increase the vessel-muscle ratio by four- to fivefold. Contrast was substantially improved and remained unchanged 2 hours after contrast medium administration, and good visualization of four orders of vasculature was allowed.

This article has been cited by other articles:

				Z. Medarova, G. Castillo, G. Dai, E. Bolotin, A. Bogdanov, and A. Moore Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 Diabetes Diabetes, November 1, 2007; 56(11): 2677 - 2682. [Abstract] [Full Text] [PDF]

				Y. R. Kim, A. Yudina, J. Figueiredo, W. Reichardt, D. Hu-Lowe, A. Petrovsky, H. W. Kang, D. Torres, U. Mahmood, R. Weissleder, et al. Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts: In vivo Changes of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase Inhibitor Cancer Res., October 15, 2005; 65(20): 9253 - 9260. [Abstract] [Full Text] [PDF]

				M. Seshadri, J. A. Spernyak, R. Mazurchuk, S. H. Camacho, A. R. Oseroff, R. T. Cheney, and D. A. Bellnier Tumor Vascular Response to Photodynamic Therapy and the Antivascular Agent 5,6-Dimethylxanthenone-4-Acetic Acid: Implications for Combination Therapy Clin. Cancer Res., June 1, 2005; 11(11): 4241 - 4250. [Abstract] [Full Text] [PDF]

				P. Reimer, C. Bremer, T. Allkemper, M. Engelhardt, M. Mahler, W. Ebert, and B. Tombach Myocardial Perfusion and MR Angiography of Chest with SH U 555 C: Results of Placebo-controlled Clinical Phase I Study Radiology, May 1, 2004; 231(2): 474 - 481. [Abstract] [Full Text] [PDF]

				R. Weissleder and U. Mahmood Molecular Imaging Radiology, May 1, 2001; 219(2): 316 - 333. [Abstract] [Full Text]

				F. Sardanelli, G. Molinari, F. Zandrino, and M. Balbi Three-dimensional, Navigator-Echo MR Coronary Angiography in Detecting Stenoses of the Major Epicardial Vessels, with Conventional Coronary Angiography as the Standard of Reference Radiology, March 1, 2000; 214(3): 808 - 814. [Abstract] [Full Text]

				U. Mahmood, C.-H. Tung, A. Bogdanov Jr, and R. Weissleder Near-Infrared Optical Imaging of Protease Activity for Tumor Detection Radiology, December 1, 1999; 213(3): 866 - 870. [Abstract] [Full Text]

				T. Allkemper, C. Bremer, L. Matuszewski, W. Ebert, and P. Reimer Contrast-enhanced Blood-Pool MR Angiography with Optimized Iron Oxides: Effect of Size and Dose on Vascular Contrast Enhancement in Rabbits Radiology, May 1, 2002; 223(2): 432 - 438. [Abstract] [Full Text] [PDF]